Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanotech workplace safety survey

This article was originally published in The Tan Sheet

Executive Summary

"Due in part to a lack of general information regarding nanomaterials risk, companies and labs have workers using conventional environmental, health and safety (EHS) practices when handling nanomaterials, even though practices were developed to deal with bulk materials that can have markedly different chemical properties than their nano-sized counterparts," the International Council on Nanotechnology (ICON) says after a Nov. 13 report. The 1report, produced by a research team from the University of California, Santa Barbara, is the first comprehensive, international survey of EHS practices in the nanotech industry. The survey and report are the second phase of a two-part project to determine how industry is managing the occupational safety risks that may be posed by nanotech, ICON says. The first-phase 2report reviewed and analyzed existing efforts to develop best practices in the industry. The National Institute of Occupational Safety & Health will review the report "with great interest," Director John Howard said...

You may also be interested in...



Roche’s Ipatasertib Promising In Prostate, But Disappointing In Breast Cancer

Roche is hoping the investigational oral drug can help it expand its presence in breast cancer and break into the prostate cancer market – but the signals are decidedly mixed.

Shuren Gives Peek Behind Curtain With 3 Lessons FDA’s Device Center Learned During Pandemic

CDRH director Jeff Shuren says the US agency’s device center has been tallying up lessons learned from the COVID-19 pandemic.

Infographic: Sleep Apnea Market To Reach Almost $10.3Bn By 2022

The market for devices to monitor and treat sleep apnea and its complications is set to grow by 7.3% annually in the next three years, with the US market expanding by 7.6% per year, according to the Meddevicetracker Dashboard.

Topics

UsernamePublicRestriction

Register

MT125529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel